This systematic review and meta-analysis brought together research on efforts to eliminate river blindness (onchocerciasis) in Cameroon through mass drug administration (MDA) of ivermectin from 2000 to 2025. The review found that MDA coverage was highly heterogeneous across districts and over time, with nearly 40% of survey-based estimates falling below the recommended 65% coverage threshold.
Programme records consistently reported higher treatment coverage than surveys found. In several areas, people did not take treatment regularly over the years. Repeated treatment greatly reduced infections, but the disease was still spreading in some places. Challenges included difficulties delivering treatment, people moving between areas, reluctance to take the medicine, and gaps in information and trust. The findings suggest that programmes need to adapt to local conditions, using community surveys, information on regular treatment use and evidence of where the disease is still spreading to guide action.